FDA Adverse Event Death Summary report: N

ENDEAVOR ZOTAROLIMUS-ELUTING CORONARY STENT MX2

MDR report key: 1083512 · Received July 29, 2008

Report

Report Number
2953200-2008-00611
Event Type
Death
Date Received
July 29, 2008
Date of Event
June 29, 2008
Report Date
June 30, 2008
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

SECONDARY INTERVENTION. EVALUATION CODES: RESULTS: SUBACUTE THROMBOSIS, MI, DEATH.

Description of Event or Problem · 1

FOUR ENDEAVOR MX2 DRUG-ELUTING CORONARY STENTS WERE SUCCESSFULLY IMPLANTED INTO A PATIENT FOR TREATMENT OF A PROXIMAL AND MID RCA; AND A PROXIMAL AND MID CIRCUMFLEX ARTERY. THE VESSEL MORPHOLOGY WAS NOT REPORTED. IT IS UNKNOWN IF THE LESION WAS PRE-DILATED. (MFR REPORT# 2953200-2008-00611-00614) IT WAS REPORTED FIVE DAYS POST STENT IMPLANT THAT THE PATIENT PRESENTED EMERGENTLY TO THE ER WITH SUB ACUTE STENT THROMBOSIS. THE PATIENT WAS REPORTED TO HAVE POBA; THEN WAS TRANSFERRED TO THE ICU. IT WAS REPORTED THAT THE PATIENT EXPIRED THE FOLLOWING DAY. THE PHYSICIAN SUSPECTS THAT THE PATIENT MAY HAVE A PLAVIX RESISTANCE ISSUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR ZOTAROLIMUS-ELUTING CORONARY STENT MX2 NIQ MEDTRONIC CARDIOVASCULAR GALWAY NA 0000636803

Patients

Seq Age Sex Outcome Treatment
1 80 YR Death| R THE PATIENT WAS ON PLAVIX PRIOR TO THE EVENT.| ASA POST PROCEDURE| THE PATIENT WAS PLACED ON PLAVIX AND